NasdaqGM - Delayed Quote USD
Summit Therapeutics Inc. (SMMT)
27.35
+2.13
+(8.45%)
At close: April 22 at 4:00:01 PM EDT
27.88
+0.53
+(1.94%)
After hours: April 22 at 7:59:29 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-142,106
-142,106
-76,760
-41,582
-72,587
Investing Cash Flow
-205,341
-205,341
-587,774
-624
-306
Financing Cash Flow
381,227
381,227
86,513
620,244
77,916
End Cash Position
105,187
105,187
71,425
648,607
71,791
Income Tax Paid Supplemental Data
--
--
52
--
7
Interest Paid Supplemental Data
8,806
8,806
10,650
434
85
Capital Expenditure
-139
-139
-128
-624
-306
Issuance of Capital Stock
477,893
477,893
109,686
100,000
75,000
Issuance of Debt
--
--
--
545,000
110,000
Repayment of Debt
-100,000
-100,000
-24,686
-25,000
-110,000
Free Cash Flow
-142,245
-142,245
-76,888
-42,206
-72,893
12/31/2021 - 3/5/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VKTX Viking Therapeutics, Inc.
25.48
+7.42%
ADMA ADMA Biologics, Inc.
21.39
+8.91%
GPCR Structure Therapeutics Inc.
23.04
-0.26%
IOVA Iovance Biotherapeutics, Inc.
3.2100
+4.22%
IBRX ImmunityBio, Inc.
2.6900
+7.17%
VERV Verve Therapeutics, Inc.
5.25
+9.83%
RXRX Recursion Pharmaceuticals, Inc.
5.63
+4.07%
QURE uniQure N.V.
14.39
+8.28%
TGTX TG Therapeutics, Inc.
37.99
+2.76%
CRSP CRISPR Therapeutics AG
39.23
+3.73%